OTC:CNBX | Free Cash Flow | CNBX Pharmaceuticals Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-08-31 to 2025-11-30
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-11-30-$47,408.00
2025-08-31-$28,545.00
2024-11-30-$39,077.00
2024-08-31-$48,250.00
2023-11-30-$71,846.00
2023-08-31$20,517.00
2022-11-30-$95,915.00
2022-08-31-$149,510.00
2021-11-30-$599,545.00
2021-08-31-$581,819.00
2020-11-30-$592,637.00
2020-08-31-$713,959.00
2019-11-30-$761,687.00
2019-08-31-$868,673.00
2018-11-30-$667,135.00
2018-08-31-$621,497.00
2017-11-30-$452,974.00
2017-08-31-$343,467.00
2016-11-30-$146,956.00
2016-08-31-$69,376.00
2015-11-30-$35,669.00$0.00-$35,669.00
2015-08-31-$27,978.00
2014-11-30-$126,109.00$3,710.00-$129,819.00
2014-08-31-$49,681.00
2013-11-30-$41,402.00
2013-08-31-$27,259.00
2012-11-30$0.00
2011-11-30$0.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-08-31-$171,305.00
2024-08-31-$244,269.00
2023-08-31-$112,521.00
2022-08-31-$1.68M
2021-08-31-$2.49M
2020-08-31-$2.77M
2019-08-31-$3.09M
2018-08-31-$1.97M
2017-08-31-$863,567.00
2016-08-31-$120,103.00
2015-08-31-$179,055.00
2014-08-31-$195,416.00
2013-08-31-$27,245.00
2010-08-31$5,999.00